Tag: pharmaceutical policy
UK Orphan Drug Registry Expands Access to Rare Disease Treatments
The UK Medicines and Healthcare products Regulatory Agency (MHRA) maintains a comprehensive registry of authorised orphan medicinal products for rare…
Eli Lilly cuts 340B drug discounts to hospitals failing to report claims data
Eli Lilly has begun eliminating federally mandated drug price breaks to hospitals that failed to submit required claims data under…
European Drug Pricing Pressures Rise as U.S. Policy Ripple Effects Spread Across Markets
European countries are adopting divergent pharmaceutical pricing policies, creating market complexity and affecting drug access. Healthcare systems face mounting pressure…
Regulatory Agencies Split on New Alzheimer’s Drugs as Hope Meets Uncertainty
Regulatory agencies worldwide are delivering conflicting assessments of novel Alzheimer's treatments, creating uncertainty for millions of patients. The Lancet examines…
Trump Drug Pricing Deals Face First Test as New Medications Launch
President Trump's most-favored-nation drug pricing agreements with 17 pharmaceutical companies face their first real-world test as new medications launch. Healthcare…